Document is current
Any future updates will be listed below
-
Authors
Tang, Megan
Worona, Leslie
Ramos, Emily
Roof, Scott
Genden, Eric
Posner, Marshall
Misiukiewicz, Krzysztof
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02945631 at ClinicalTrials.govnct05376553 at ClinicalTrials.govDocuments that mention this clinical trial
The Quarterback trials: A phase 2 series of sequential studies of induction chemotherapy followed by reduced dose chemoradiation for human papillomavirus positive oropharynx cancer.
https://doi.org/10.1200/jco.2023.41.16_suppl.6020
47 Early molecular response kinetics to induction chemotherapy and anti-PD1 immunotherapy in HPV-positive head and neck squamous cell carcinoma (HNSCC) patients
https://doi.org/10.1136/jitc-2024-sitc2024.0047
nct02945631 at ClinicalTrials.govDocuments that mention this clinical trial
47 Early molecular response kinetics to induction chemotherapy and anti-PD1 immunotherapy in HPV-positive head and neck squamous cell carcinoma (HNSCC) patients
https://doi.org/10.1136/jitc-2024-sitc2024.0047
nct05376553 at ClinicalTrials.govDocuments that mention this clinical trial
The Quarterback trials: A phase 2 series of sequential studies of induction chemotherapy followed by reduced dose chemoradiation for human papillomavirus positive oropharynx cancer.
https://doi.org/10.1200/jco.2023.41.16_suppl.6020
47 Early molecular response kinetics to induction chemotherapy and anti-PD1 immunotherapy in HPV-positive head and neck squamous cell carcinoma (HNSCC) patients
https://doi.org/10.1136/jitc-2024-sitc2024.0047
Documents that mention this clinical trial
47 Early molecular response kinetics to induction chemotherapy and anti-PD1 immunotherapy in HPV-positive head and neck squamous cell carcinoma (HNSCC) patients
https://doi.org/10.1136/jitc-2024-sitc2024.0047
- License Information
